United Laboratories Intl

United Laboratories Intl Overview

Status Public
Employees 13,000
Stock Symbol 03933
Stock Symbol
Share Price $0.88 (As of Thursday Closing)

United Laboratories Intl General Information


United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, capsule casings, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • New Territories
  • Hong Kong
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

United Laboratories Intl Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.88 $0.87 $0.47 - $0.98 $1.54B 1.74B 8.3M $0.06

United Laboratories Intl Financials Summary

In Thousands,
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,462,930 1,462,930 1,356,852 1,921,194
Revenue 1,214,748 1,214,748 1,135,339 1,010,165
EBITDA 252,871 252,871 266,922 162,640
Net Income 92,889 92,889 103,235 12,098
Total Assets 2,243,839 2,243,839 2,122,735 2,161,513
Total Debt 714,353 714,353 618,184 743,947
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ready to get started?

Request a free trial